Human fibrinogen, Human thrombin

Tachosil Matriz Adhesiva

5,5 mg + 2 UI matriz adhesivaSpainMarketedAuthorised 2 Dec 2004

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Human fibrinogen, Human thrombin

Tachosil Matriz Adhesiva

5,5 mg + 2 UI matriz adhesivaSpainMarketedAuthorised 2 Dec 2004

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

VeraSeal 80mg/ml oplossing voor weefsellijmNetherlands · Weefsellijm · Instituto Grifols S.A.

VeraSealSaudi Arabia · Instituto Grifols, S.A.

VeraSeal Solutions for sealantTaiwan · 液劑 · 壯生醫療器材股份有限公司

EVICEL Fibrin SealantTaiwan · 液劑 · 壯生醫療器材股份有限公司

VERASEAL SOLUTIONS FOR SEALANT, 80 mg/ml, 500 IU/mlSingapore · 80 mg/ml + 500 IU/ml · solution · Grifols Asia Pacific Pte. LTD.

Packs

Pack	Code	Status
TACHOSIL MATRIZ ADHESIVA , 1 esponja de 9,5 x 4,8 cm	650310

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Human fibrinogen, Human thrombin
Strength: 5,5 mg + 2 UI
Dosage form: matriz adhesiva
Route: uso epilesional
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 2 Dec 2004
Registration: 04277001
Marketing authorisation holder: Corza Medical Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario

Tachosil Matriz AdhesivaHuman fibrinogen + Human thrombin · 5,5 mg + 2 UI · matriz adhesivaSpain

Veraseal Soluciones Para Adhesivo TisularHuman fibrinogen + Human thrombin · 80 mg + 500 UI · solución para adhesivo tisularSpain

Evarrest Matriz AdhesivaHuman fibrinogen + Human thrombin · 8,6 mg + 37,5 UI · matriz adhesivaSpainWithdrawn

Raplixa Polvo Adhesivo TisularHuman fibrinogen + Human thrombin · 79 mg/g + 726 UI/g · polvo adhesivo tisularSpainWithdrawn